Medical Research
(H05)
990 on File
PEPTIDE THERAPEUTICS FOUNDATION
Financial strength (30%)
71/100
Reliability (20%)
50/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$174K
Total Revenue
$145K
Total Expenses
$335K
Net Assets
N/A
Employees
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
27.81x
Liability-to-Asset
N/A
Revenue Diversification
N/A
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 84.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
27.8 mo | 13.4 mo |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
29.4% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-8.4% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
17.1% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $174K | $145K | $335K | 100.0% | — |
| 2023 | $135K | $158K | $287K | 100.0% | — |
| 2022 | $110K | $129K | $281K | 100.0% | — |
| 2021 | $96K | $116K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.